Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1843 of 6351
-
New eczema drug shows promise in 2-Year extension trial
Disease control CompletedThe main purpose of the study is to assess the long-term tolerability and effectiveness of lebrikizumab in adult and adolescent participants with moderate-to-severe atopic dermatitis (AD). Participants who complete the last assessment visit in ADjoin (Week 100) will be offered th…
Phase 3 • Sponsor: Almirall, S.A. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug FOG-001 takes on Hard-to-Treat cancers
Disease control Recruiting nowThe goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic solid tumors or in participants with familial adenomatous polyposis (FAP).
Phase 1/2 • Sponsor: Parabilis Medicines, Inc. • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New implant aims to fuse painful pelvic joint
Disease control OngoingiFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction (STACI) is a prospective, multicenter, study of SIJ fusion using the iFuse TORQ implant system.
Phase 4 • Sponsor: SI-BONE, Inc. • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Could junk food chemicals show up in breast milk?
Knowledge-focused CompletedIn last decades, a change in dietary habits has been observed in industrialized countries characterized by a drastic increase in the consumption of ultra-processed foods (UPF, Ultra-Processed Foods). As defined by the NOVA classification, UPFs are industrial formulations of food …
Sponsor: Federico II University • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
New hope for AML patients: maintenance chemo combo aims to keep remission going
Disease control Recruiting nowThis is a phase IB/II study with a 3+3 dose de-escalation study design. Patients will continue maintenance treatment with CPX-351 for 6 cycles on D1 and D3, as long as patient remains in CR. The dose de-escalation will be one dose given on D1 only, every 28 days pending toxicity.…
Phase 1/2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
ChatBot keeps tabs on cancer patients, could cut hospital trips
Symptom relief OngoingEvaluate the feasibility of using a chatbot combined with continuous activity monitoring to proactively identify, appropriately triage and help manage patients' symptoms during cancer treatment Determine whether such an early outpatient clinic-based intervention can decrease rate…
Phase 2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Magnetic pulses may tame deadly heart storms
Symptom relief Recruiting nowThree-arm randomized clinical trial comparing two strategies of TcMS to sham stimulation in patients with VT storm. The hypothesis of the study is that TcMS will reduce the burden of VT in the 24 hours after randomization compared to sham stimulation and that TcMS with theta burs…
Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New bladder pain cocktail aims to ease Flare-Ups fast
Symptom relief Recruiting nowThis is a Phase 2, prospective, randomized, double-blind, placebo-controlled, multi-center, single-dose, pharmacodynamic study designed to evaluate the efficacy and safety of the combination product (VNX001) versus placebo and its individual components (heparin sodium and lidocai…
Phase 2 • Sponsor: Vaneltix Pharma, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
New cocktail of drugs and radiation targets tough pancreatic tumors
Disease control OngoingThis phase I trial tests the safety and tolerability of olaparib in combination with durvalumab and radiation therapy in patients with pancreatic cancer that has spread to nearby tissue or lymph nodes (locally advanced) and cannot be removed by surgery (unresectable). Olaparib is…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New shot could cut opioid use after bunion surgery
Symptom relief CompletedSubjects receive study drug during bunionectomy and are followed for pain and opioid use, with the hypothesis that those who receive CPL-01 will have less pain and less opioid use than either control arm.
Phase 3 • Sponsor: Cali Pharmaceuticals LLC • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
New program aims to protect HIV patients from HPV cancer
Prevention OngoingPeople living with HIV (PLWH) are 28 times more likely to be diagnosed with Human Papillomavirus (HPV) - associated anal cancer than the general population. The HPV vaccine is an effective and safe approach to prevent and reduce the risk of HPV-related disease among PLWH. HPV vac…
Sponsor: Emory University • Aim: Prevention
Last updated Jun 27, 2026 12:34 UTC
-
AI could spot hidden heart attack risks before It's too late
Knowledge-focused Recruiting nowCoronary artery disease (CAD) is among the leading cause of death and disability. Identification of patients at high risk of cardiovascular events is pivotal. However, current risk stratification based on imaging and known biomarkers is suboptimal. The objective of this proposal …
Sponsor: Centro Cardiologico Monzino • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
MS drug may shield eyes from damage, new study hopes to prove
Disease control By invitation onlyThis study aims to assess whether, and the degree to which, ofatumumab modulates or reduces rates of retinal atrophy in people with relapsing-remitting MS (RMS), according to baseline serum neurofilament light chain (sNfL) levels.
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Brain zaps and mindfulness: a new hope for veterans in pain?
Symptom relief CompletedVeterans with comorbid chronic pain and depression are highly prevalent, have poor functional status and low quality of life, are at increased risk of suicide and lack access to effective treatments. To address this problem, the proposed research will examine the feasibility of a…
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
Spine surgery breakthrough? bone marrow clot may speed up fusion
Disease control OngoingSpinal fusion (SF) is a common orthopedic procedure to treat spinal diseases. Apart from fixation systems, the procedure requires bone grafting to further improve SF. Cell-based therapies as vertebral bone marrow aspirate (vBMA) with bone allograft were developed as alternative t…
Sponsor: Istituto Ortopedico Rizzoli • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Keto vs. Low-Fat: which diet helps heart failure patients move better?
Disease control Recruiting nowThis study is being done to evaluate the effects of a low carbohydrate ketogenic diet (KD) versus a low-fat diet (MD) on exercise tolerance in participants with heart failure with normal pumping function and diabetes or pre-diabetes, or metabolic syndrome, or obesity.
Sponsor: Ohio State University • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New Three-Drug cocktail aims to tackle relapsed lymphoma
Disease control OngoingTo find a recommended dose of valemetostat that can be given in combination with rituximab and lenalidomide to patients with follicular lymphoma. The safety and effects of this drug combination will also be studied
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Electric implant aims to restore erections after prostate cancer surgery
Disease control Recruiting nowThe goal of this clinical trial is to assess if a new device is safe to use as a potential treatment for erectile dysfunction following radical prostatectomy. The main questions it aims to answer are: * Is the device safe? * Does the device works well? Are the participants sati…
Sponsor: Comphya Australia • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New drug cocktail shows promise for slowing kidney disease
Disease control CompletedThis was a 28-week, open-label, multicenter, single-group Phase 2 exploratory study to determine the safety and effect of sparsentan in participants with IgAN who are at risk of disease progression to kidney failure despite being on both stable RAASi and SGLT2 inhibitor treatment…
Phase 2 • Sponsor: Travere Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Ancient acupoint massage meets modern exercise: a new hope for aging muscles and sleep?
Disease control Recruiting nowThe purpose of this study is to evaluate the clinical efficacy and impact of digital/remote courses combining traditional Chinese medicine (TCM) acupoint-stimulated interventions, health education, and exercise on sarcopenia and sleep disturbances across distinct age groups. By i…
Sponsor: Tainan Hospital, Ministry of Health and Welfare • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC